EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance to specific SARS-CoV-2 Subvariants

New safety information - Product safety - COVID

Date

2023-01-17

Country

Canada

Product

EVUSHELD (tixagevimab and cilgavimab for injection)

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2023-01-18
2. CA
   Drugs & medicalType II

   Nuzone X2 Synthetic Polychloroprene Sterile Surgical Gloves Powder Free

   Performance

   Health CanadaOfficial notice →
3. CA
   Drugs & medicalType II

   Novaguide Intelligent Ultrasound System

   Performance

   Health CanadaOfficial notice →
4. 2023-01-17
5. CA
   Drugs & medicalType II

   Permanent Life Support and HLS Sets

   Sterility

   Health CanadaOfficial notice →
6. 2023-01-13
7. CA
   Drugs & medicalType II

   Cannula, Neonate, Oxygen W/3-Channel Tube 7' - 50/Cs

   Labelling and packaging - Performance

   Health CanadaOfficial notice →
8. CA
   Drugs & medicalType II

   Digital TENS/EMS

   Unauthorised device

   Health CanadaOfficial notice →
9. 2023-01-12
10. CA
    Drugs & medicalType II

    Somatom X.Cite

    Performance

    Health CanadaOfficial notice →